Detection method and content determining method of sodium calcium edetate in pantoprazole sodium for injecting
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- CHENGDU BAIYU JINGELAI PHARMA CO LTD
- Publication Date
- 2012-11-28
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
Technical field
[0001] The invention belongs to the field of drug analysis, and specifically relates to a detection method and a content determination method of the auxiliary material calcium sodium edetate in pantoprazole sodium for injection. Background technique
[0002] Pantoprazole sodium for injection is mainly used for acute upper gastrointestinal bleeding caused by duodenal ulcer, gastric ulcer, acute gastric mucosal disease, compound gastric ulcer, etc. This product has a low affinity with liver cytochrome P450. It also has a phase II metabolic pathway, so it has less interaction with other drugs metabolized by cytochrome P450 enzymes than omeprazole and lansoprazole. In addition, pantoprazole sodium is susceptible to the catalytic hydrolysis of metal ions, which affects the stability of the product during preparation and instillation. Therefore, it is necessary to add a metal ion complexing agent, and disodium edetate is added to all commercially available samples. How...